Organ transplantation and vaccination
Organ Transplantation
; 13(1):6-11, 2022.
Article
in Chinese
| EMBASE | ID: covidwho-2322395
ABSTRACT
Organ transplant recipients are at a high risk of infection with high hospitalization rate, critical rate and fatality, due to low immune function caused by taking immunosuppressants for a period of long time after organ transplantation. Currently, vaccination is recognized as an effective approach to prevent infection. Organ transplant recipients may be vaccinated according to individual conditions. However, the sensitivity to vaccines may decline in organ transplant recipients. The types, methods and timing of vaccination have constantly been the hot spots of clinical trials. In this article, the general principles, specific vaccines and SARS-CoV-2 vaccines of vaccination in organ transplant recipients were briefly reviewed, aiming to provide reference for the vaccination of organ transplant recipients. Moreover, current status of SARS-CoV-2 vaccination for organ transplant recipients was illustrated under the global outbreak of novel coronavirus pneumonia pandemic.Copyright © 2022 Journal of Zhongshan University. All Rights Reserved.
Hepatitis A vaccine; Hepatitis B vaccine; Human papillomavirus vaccine; Influenza vaccine; Organ transplantation; Pneumococcal vaccine; Rabies vaccine; SARS-CoV-2 vaccine; Tetanus vaccine; article; coronavirus disease 2019/dt [Drug Therapy]; coronavirus disease 2019/pc [Prevention]; graft recipient; human; pandemic; priority journal; vaccination; Human papilloma virus vaccine; Pneumococcus vaccine; SARS-CoV-2 vaccine/dt [Drug Therapy]; tetanus toxoid; vaccine
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
Chinese
Journal:
Organ Transplantation
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS